By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 4th TIL Therapies Summit Commercialization looks set to propel TIL therapy into the spotlight for adoptive cell therapy, and the 4th TIL Therapies Summit arrives to finally reunite the community in-person this October.
Explore the potential of adoptive t-cell therapy to drive toward approved cell therapies in solid tumors and enhancing stemness of polyclonal t cells.
Discover ways to address the next generation of therapies to expand the benefits of TIL across multiple indications.
Network with industry experts like Andrew Weinberg, Daniel Powell, Eduardo Davila, Karrie Wong, Mark Dudley and others.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf.
Collecting over a million blood products each year, our network of community based blood centers have the donors and experience needed to ensure products required for cell therapy manufacturing and medical research are always available.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.